Abstract:Background Surgical resection is often the preferred treatment for non-small cell lung cancer (NSCLC) patients. Predictive biomarkers after surgery can help monitoring and treating patients promptly, so as to improve the clinical outcome. In this study, we evaluated one potential candidate biomarker, the folate receptor-positive circulating tumor cell (FR + CTC), by investigating its prognostic and predictive significance in NSCLC patients who underwent surgery. Methods In this prospective, observational study, we enrolled NSCLC patients who were eligible to receive surgery. Prior to operation, peripheral blood was collected from each patient for an FR + CTC analysis. FR + CTCs were isolated by negative enrichment using immunomagnetic beads to deplete leukocytes and then quantitatively detected by a ligand-targeted polymerase chain reaction (PCR) method. These patients were then given standard care and were actively followed up for seven years. At the end of the follow-up period, the association between the FR + CTC level and the prognosis in these patients was evaluated. Results Overall, preoperative FR + CTC level was not significantly different among NSCLC patients with adenocarcinoma or non-adenocarcinoma subtypes ( P = 0.24). However, between patients with low- and high-risk pathological adenocarcinoma subtypes, the preoperative FR + CTC level was significantly different ( P = 0.028). Further, patients with lower preoperative FR + CTC level had longer relapse-free survival (RFS) and overall survival (OS) than those with higher preoperative FR + CTC level (RFS: not reached vs. 33.3 months, P = 0.018; OS: not reached vs. 72.0 months, P = 0.13). In a multivariate COX regression analysis, FR + CTC level (HR = 4.10; 95% CI, 1.23–13.64; P =0.022) and pathological stage (HR = 3.16; 95% CI, 1.79–10.14; P = 0.0011) were independent prognostic factors of RFS. Moreover, FR + CTC level together with adenocarcinoma subtypes provided additional information on risk for disease recurrence compared with FR + CTC or adenocarcinoma subtype alone. Conclusion Our study demonstrated that the preoperative FR + CTC level was a potential predictor for the prognosis of NSCLC patients underwent surgery. Further, when preoperative FR + CTC level is considered together with primary tumor proliferation characteristics, its prognostic value supplements that of these conventional pathological features.

Back Cover: Predictive Value of Folate Receptor‐Positive Circulating Tumor Cells for the Preoperative Diagnosis of Lymph Node Metastasis in Patients with Lung Adenocarcinoma (Small Methods 6/2021)

Clinical Value of High Frequency Ultrasound Guided FNA and Washout Fluid Thyroglobulin Detection for Diagnosing Lateral Neck Lymph Nodes Metastasis of Thyroid Carcinoma

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients

Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection

Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer

Predictive Risk Factors for Lymph Node Metastasis in Patients with Small Size Non-Small Cell Lung Cancer.

Clinical significance of postoperative folate receptor‐positive circulating tumor cells (FR + CTCs) for long‐term prognosis in patients with invasive adenocarcinoma (IAC) of the lung

Folate Receptor-Positive Circulating Tumor Cells Predict Survival and Recurrence Patterns in Patients Undergoing Resection for Pancreatic Cancer

Predictive value of 18F-FDG PET-CT for lymph node metastasis of peripheral lungadenocarcinoma

Identify the Clinicopathological Characteristics of Lung Carcinoma Patients Being False Negative in Folate Receptor Based Circulating Tumor Cell Detection

Preoperative prediction of occult lymph node metastasis in patients with non-small cell lung cancer: a simple and widely applicable model

A liquid biopsy assay for the noninvasive detection of lymph node metastases in T1 lung adenocarcinoma

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules

Deep Learning Analysis Using 18F-FDG PET/CT to Predict Occult Lymph Node Metastasis in Patients With Clinical N0 Lung Adenocarcinoma

Overcoming Obstacles In Pathological Diagnosis Of Pulmonary Nodules Through Circulating Tumor Cell Enrichment

Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China

The Value of Pulmonary Nodule Diameter and Consolidation/tumor Rate in the Prediction of Lymph Node Metastasis in Early-Stage (ct1n0m0) Lung Adenocarcinoma.

Evaluating peritumoral and intratumoral radiomics signatures for predicting lymph node metastasis in surgically resectable non-small cell lung cancer

Preoperative predictive model for the probability of lymph node metastasis in gastric cancer: a retrospective study

Preoperative computed tomography semantic features in predicting lymph node metastasis of part-solid nodules in non-small cell lung cancer: a multicenter retrospective study

Integrative Predictive Models of Computed Tomography Texture Parameters and Hematological Parameters for Lymph Node Metastasis in Lung Adenocarcinomas